| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PARP7-IN-15 CAS:2819998-97-3 Package:50mg/RMB 24300
|
|
| | PARP7-IN-15 Basic information |
| Product Name: | PARP7-IN-15 | | Synonyms: | PARP7-IN-15;3(2H)-Pyridazinone, 5-[(2S)-2-[[3-oxo-3-[(6aS)-6a,7,9,10-tetrahydro-3-(trifluoromethyl)pyrazino[1,2-d]pyrido[3,2-b][1,4]oxazin-8(6H)-yl]propoxy]methyl]-1-azetidinyl]-4-(trifluoromethyl)- | | CAS: | 2819998-97-3 | | MF: | C23H24F6N6O4 | | MW: | 562.47 | | EINECS: | | | Product Categories: | | | Mol File: | 2819998-97-3.mol |  |
| | PARP7-IN-15 Chemical Properties |
| density | 1.646±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 9.080±0.60(predicted) | | form | Solid | | color | White to off-white |
| | PARP7-IN-15 Usage And Synthesis |
| Uses | PARP7-IN-15 (Compound 18) is a PARP7 inhibitor with IC50 of 0.56 nM, that has antitumor activity[1]. | | IC 50 | PARP7: 0.56 nM (IC50) | | References | [1] Silong Zhang , et al. Exploring the structural-activity relationship of hexahydropyrazino[1,2-d]pyrido[3,2-b][1,4]oxazine derivatives as potent and orally-bioavailable PARP7 inhibitors. Eur J Med Chem. 2023 Oct 8:261:115836. DOI:10.1016/j.ejmech.2023.115836 |
| | PARP7-IN-15 Preparation Products And Raw materials |
|